Restrictive lung disease
Sarco i Dosi
0830 - Lee Restrictive Lung DZ
Interstitial lung disease
Idiopathic Interstitial Pneumonia
OFEV ® (nintedanib) INPULSIS ® trial design and baseline characteristics Last updated 08.09.2015 These slides are provided by Boehringer Ingelheim for.
